Skip to main content

Advertisement

Log in

Gonadal dysfunction in male patients with Budd Chiari syndrome and its reversibility with treatment

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background and aims

Budd Chiari syndrome (BCS) commonly affects adolescents and adults. With improved survival, important quality-of-life parameters such as sexual life and fertility become more relevant. This study was aimed to assess the gonadal function in male patients with BCS and the effect of treatment on gonadal function.

Methods

Thirty male patients with newly diagnosed BCS were prospectively assessed for the presence of gonadal dysfunction. Erectile function was assessed using standardized International Index of Erectile Function questionnaire (IIEF). Follicular stimulating hormone (FSH), luteinizing hormone (LH), sex hormone-binding globulin (SHBG), estradiol, total testosterone (TT), calculated free testosterone (cFT), calculated bioavailable testosterone (cBT), sperm count, and sperm motility were compared at baseline and at 6 months of treatment for the assessment of gonadal function.

Results

Sixteen (53.3%) out of 30 patients were sexually active at the time of study and 5/16 (31%) had erectile dysfunction. Hypogonadotropic hypogonadism (HH) was the most common pattern seen in 50% cases followed by hypergonadotropic hypogonadism (HyH) in 23% cases. 27% patients had eugonadism. At 6 months of treatment, 60% of patients in HH group became eugonadal as compared to only 14% in HyH group. Proportion of patients with erectile dysfunction reduced (5/16 vs 1/16) after 6 months of therapy. The improvement in sperm count and sperm motility was not significant.

Conclusion

Gonadal dysfunction is common in male patients with BCS. HH remains the most common type of hypogonadism BCS and the type which improves significantly after treatment.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data transparency

All data and materials as well as software application or custom code support their published claims and comply with field standards.

Data availability

Datasets generated and analyzed during the current study are available from the corresponding author on request.

Code availability (software application or custom code)

Not applicable.Not applicable.

Plant reproducibility

Current article does not contain any research related to plants; hence, this part is not applicable to current article.

Abbreviations

LH:

Luteinizing hormone

SHBG:

Sex hormone-binding globulin

BCS:

Budd Chiari syndrome

IIEF:

International index of erectile function

FSH:

Follicular stimulating hormone

cFT:

Calculated free testosterone

cBT:

Calculated bioavailable testosterone

CTP:

Child–Turcotte–Pugh

MELD:

Model for end-stage liver disease

HH:

Hypogonadotropic hypogonadism

HyH:

Hypergonadotropic hypogonadism

References

  1. Kharb S, Garg MK, Puri P, Brar KS, Pandit A, Srivastava S. Assessment of thyroid and gonadal function in liver diseases. Indian J Endocrinol Metab 2015;19(1):89–94

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005;152(4):501–513

    Article  CAS  PubMed  Google Scholar 

  3. Gonzales PH, Rhoden CR, Luz C, Corrêa G, Barbosa-Coutinho LM, Oliveira MC. Male gonadal function, prolactin secretion and lactotroph population in an experimental model of cirrhosis. Braz J Med Biol Res 2007;40(10):1383–1388

    Article  CAS  PubMed  Google Scholar 

  4. Bandyopadhyay SK, Moulick A, Saha M, Dutta A, Bandyopadhyay R, Basu AK. A study on endocrine dysfunction in adult males with liver cirrhosis. J Indian Med Assoc 2009;107(12):866–869

    PubMed  Google Scholar 

  5. Kim M, Kim SY, Rou WS, Hwang SW, Lee BS. Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin Mol Hepatol 2015;21(4):352–357

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bannister P, Losowsky MS. Sex hormones and chronic liver disease. J Hepatol 1988;6(2):258–262

    Article  CAS  PubMed  Google Scholar 

  7. Serin A, Akarsu M, Akpinar H, Simsek I. Changes of some hormones levels in patients with Hepatitis b virus-related chronic liver disease. Gastroenterol Res 2013;6(4):134–138

    CAS  Google Scholar 

  8. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;350(6):578–585

    Article  CAS  PubMed  Google Scholar 

  9. Shukla A, Sadalage A, Gupta D, Gupte A, Mahapatra A, Mazumder D, et al. Pregnancy outcomes in women with Budd Chiari syndrome before onset of symptoms and after treatment. Liver Int 2018;38(4):754–759

    Article  PubMed  Google Scholar 

  10. Huyghe E, Kamar N, Wagner F, Capietto AH, El-Kahwaji L, Muscari F, et al. Erectile dysfunction in end-stage liver disease men. J Sex Med 2009;6(5):1395–1401

    Article  PubMed  Google Scholar 

  11. Burra P, Germani G, Masier A, et al. Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? Transplantation 2010;89(12):1425–1429

    Article  PubMed  Google Scholar 

  12. Chien YC, Chiang HC, Lin PY, Chen YL. Erectile function in men with end-stage liver disease improves after living donor liver transplantation. BMC Urol 2015;15:83

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chiang HC, Chien YC, Lin PY, Lee HL, Chen YL. Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings. PLoS ONE 2018;13(11): e0206438

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol 2010;29(1):8–11

    Article  PubMed  Google Scholar 

  15. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84(10):3666–3672

    Article  CAS  PubMed  Google Scholar 

  16. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010;16(3):231–245

    Article  PubMed  Google Scholar 

  17. Gariani K, Toso C, Philippe J, Orci LA. Effects of liver transplantation on endocrine function: a systematic review. Liver Int 2016;36(10):1401–1411

    Article  CAS  PubMed  Google Scholar 

  18. Chan MY, Chok KSH, Fung JYY, Ng SL, Yiu MK, Lo CM. Prospective study on sexual dysfunction in male Chinese liver transplant recipients. Am J Mens Health 2019;13(2):1557988319835139

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49(6):822–830

    Article  CAS  PubMed  Google Scholar 

  20. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985;60(3):444–450

    Article  CAS  PubMed  Google Scholar 

  21. DeBaun MR. Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review. Expert Rev Hematol 2014;7(6):767–773

    Article  CAS  PubMed  Google Scholar 

  22. Berthaut I, Guignedoux G, Kirsch-Noir F, de Larouziere V, Ravel C, Bachir D, et al. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica 2008;93(7):988–993

    Article  CAS  PubMed  Google Scholar 

  23. Jones KM, Niaz MS, Brooks CM, Roberson SI, Aguinaga MP, Hills ER, et al. Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints. Int J Environ Res Public Health 2009;6(3):1124–1144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zietz B, Lock G, Plach B, Drobnik W, Grossmann J, Schölmerich J, et al. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003;15(5):495–501

    CAS  PubMed  Google Scholar 

  25. Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: abnormalities and implications. J Gastroenterol Hepatol 2015;30(2):244–251

    Article  PubMed  Google Scholar 

  26. Nitsche R, Coelho JC, Freitas AC, Zeni Neto C, Martins E. Testosterone changes in patients with liver cirrhosis before and after orthotopic liver transplantation and its correlation with MELD. Arq Gastroenterol 2014;51(1):59–63

    Article  PubMed  Google Scholar 

  27. Madersbacher S, Grünberger T, Maier U. Andrological status before and after liver transplantation. J Urol 1994;151(5):1251–1254

    Article  CAS  PubMed  Google Scholar 

  28. Griswold MD. Spermatogenesis: the commitment to meiosis. Physiol Rev 2016;96(1):1–17

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Dinesh Uchil and Dr. Varsha Kale for their kind support at MRU Laboratory.

Funding

The study was funded by the Multidisciplinary Research Unit (MRU), Seth GSMC & KEM Hospital, Department of Health research, Govt. of India.

Author information

Authors and Affiliations

Authors

Contributions

Concept and design: AS and HD; consent and recruitment of participants: NR, VK, and AK; collection of blood samples and laboratory work: KK; data curation: NR and KK; data analysis and interpretation: NR, AK (Aditya Kale), SS, and AS; original manuscript: NR and KK; review and editing of manuscript: AS, SS, RS, TB, HD, and SP; supervision: SB, SS, and AS.

Corresponding author

Correspondence to Akash Shukla.

Ethics declarations

Conflict of interest

Nitin Ramani, Kashmira Kawli, Abhijeet Karad, Aditya Kale, Vinit Kahalekar, Sridhar Sundaram, Shobna Bhatia, Ravikumar Shah, Tushar Bandgar, Hemant Deshmukh, Sujata Patwardhan, and Akash Shukla declare that we have no conflict of interest.

Consent to participate (include appropriate statements)

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.

Animal studies

This article does not contain any studies with animal subjects.

Ethical approval

Ethics committee approval was obtained. Letter reference no-EC/OA-55/2016.

Consent for publication (include appropriate statements)

The work has not been published before (except in the form of an abstract or as part of a published lecture, review or thesis). The work is not under consideration elsewhere. Copyright has not been breached in seeking its publication. The publication has been approved by all co-authors and responsible authorities at the institute or organization where the work has been carried out.

Clinical trial registration

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramani, N., Kawli, K., Karad, A. et al. Gonadal dysfunction in male patients with Budd Chiari syndrome and its reversibility with treatment. Hepatol Int 16, 640–648 (2022). https://doi.org/10.1007/s12072-022-10316-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-022-10316-9

Keywords

Navigation